NICE issues final positive recommendation for National Commissioning of Soliris(R)
Alexion announced that the National Institute for Health and Care Excellence Highly Specialised Technologies Evaluation Committee has recommended that Soliris® (eculizumab) be commissioned for all patients in England suffering from atypical hemolytic uremic syndrome. November 27, 2014